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5 Abstract 
 
Pregnancy is a dynamic state and the placenta is a temporary organ that, among other 
important functions, plays a crucial role in the transport of nutrients and metabolites 
between the mother and the fetus, which is essential for a successful pregnancy. 
Among these nutrients, glucose is considered a primary source of energy and, therefore, 
fundamental to insure proper fetus development. Several studies have shown that glucose 
uptake is dependent on several morphological and biochemical placental conditions. 
Oxidative stress results from the unbalance between reactive oxygen species (ROS) and 
antioxidants, in favor of the first. During pregnancy, ROS, and therefore oxidative stress, 
increase, due to increased tissue oxygenation. Moreover, the relation between ROS and some 
pathological conditions during pregnancy has been well established.  
For these reasons, it becomes essential to understand if oxidative stress can compromise the 
uptake of glucose by the placenta. 
To make this study possible, a trophoblastic cell line, the BeWo cell line, was used. 
Experiments regarding glucose uptake, either under normal or oxidative stress conditions, 
were conducted using tert-butylhydroperoxide (tBOOH) as an oxidative stress inducer, and 
3H-2-deoxy-D-glucose (3H-DG) as a glucose analogue. Afterwards, studies regarding the 
involvement of glucose facilitative transporters (GLUT) and the phosphatidylinositol 3-
kinases (PI3K) and protein kinase C (PKC) pathways were conducted, also under normal and 
oxidative stress conditions. A few antioxidants, endogenous and from diet, were also tested in 
order to study their possible reversible effect of the oxidative effect of tBOOH upon apical 3H-
DG uptake. Finally, transepithelial studies gave interesting insights regarding the apical-to-
basolateral transport of 3H-DG. 
Results showed that 3H-DG uptake, in BeWo cells, is roughly 50% GLUT-mediated and that 
tBOOH (100 μM; 24h) decreases apical 3H-DG uptake in BeWo cells by about 33%, by 
reducing both GLUT- (by 28%) and non-GLUT-mediated (by 40%) 3H-DG uptake. Uptake of 
3H-DG and the effect of tBOOH upon 3H-DG uptake are not dependent on PKC and PI3K. 
Moreover, the effect of tBOOH is not associated with a reduction in GLUT1 mRNA levels. 
Resveratrol, quercetin and epigallocatechin-3-gallate, at 50 μM, reversed, by at least 45%, the 
effect of tBOOH upon 3H-DG uptake. Transwell studies show that the apical-to-basolateral 
transepithelial transport of 3H-DG is increased by tBOOH. 
In conclusion, our results show that tBOOH caused a marked decrease in both GLUT and non-
GLUT-mediated apical uptake of 3H-DG by BeWo cells. Given the association of increased 
oxidative stress levels with several important pregnancy pathologies, and the important role 
of glucose for fetal development, the results of this study appear very interesting. 
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7 Resumo  
 
A gravidez é um estado dinâmico e a placenta o órgão temporário que, entre diversas e 
importantes funções, apresenta o papel fundamental de ser responsável pela troca de 
nutrientes, e metabolitos, entre a mãe e o feto, essenciais para uma gravidez bem-sucedida. 
Dentro da classe dos nutrientes, a glicose apresenta-se como a fonte primordial de energia 
para o feto, sendo portanto imprescindível para o correto desenvolvimento deste. Vários 
estudos demostram que a absorção de glicose, ao nível da placenta, está dependente de 
diversas condições morfológicas e bioquímicas.  
O stresse oxidativo resulta de um desequilíbrio entre as espécies reactivas de oxigénio (ROS: 
reactive oxygen species) e antioxidantes, em favorecimento dos primeiros. Durante a gravidez, 
estas espécies, e portanto o stresse oxidativo, aumentam devido ao aumento da oxigenação 
dos tecidos placentários. Adicionalmente, a relação entre ROS e diversas patologias na 
gravidez já foi bem estabelecida.  
Por estas razões, torna-se essencial compreender se o stresse oxidativo poderá comprometer 
a absorção da glicose ao nível da placenta. 
Para tal, uma linha celular, as células BeWo, foi usada. Experiências relacionadas com a 
absorção de glicose, sob condições normais e de stresse oxidativo foram feitas usando o tert–
butilhidroperóxido (tBOOH) como indutor de stresse e um análogo radioactivo da glicose, a 
3H-2-desoxi-D-glicose (3H-DG). Posteriormente, estudos sobre o papel dos transportadores 
facilitativos de glicose (GLUT) e de algumas vias de sinalização, phosphatidilinositol 3-cinases 
(PI3K) and proteína cinase C (PKC), na absorção da 3H-DG, em condições normais e de stresse 
oxidativo, bem como o potencial efeito de reversão de alguns antioxidantes, endógenos e da 
dieta, foram feitos. Finalmente, foram ainda realizados estudos sobre o papel do stresse 
oxidativo no transporte transepitelial, no sentido apical-basolateral, de 3H-DG. 
Os resultados obtidos mostram que aproximadamente 50% do transporte da 3H-DG nas 
células BeWo é mediado pelo GLUT e que o tBOOH (100 μM; 24h) reduz essa absorção em 
cerca de 33%, reduzindo quer a captação mediada pelo GLUT (em 28%) quer a captação não 
mediada pelo GLUT (em 40%). A captação de 3H-DG e o efeito do tBOOH nessa mesma 
captação não são dependentes nem da PKC nem da PI3K. . Adicionalmente, o efeito do tBOOH 
não está associado a uma redução nos níveis de RNAm do GLUT1. O resveratrol, a quercetina 
e epigalocatequina-3-galato, 50 μM, reverteram, em pelo menos 45%, o efeito do tBOOH na 
captação de 3H-DG. Estudos em Transwells mostram que o transporte transepitelial de 3H-DG, 
no sentido apical-basolateral, aumenta em resposta ao tBOOH. 
Em conclusão, este estudo mostra que o tBOOH causa uma redução marcada na captação de 
3H-DG, quer mediada pelo GLUT, quer não mediada pelo GLUT, em células BeWo. Sabendo 
que um aumento nos níveis de stresse oxidativo está associado a numerosas patologias da 
gravidez, e que a glicose é um nutriente essencial para o feto, os resultados deste estudo 
parecem-nos de facto importantes.  
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9.1 The placenta and the fetus 
Pregnancy is a dynamic state that begins with an important stage, the embryogenesis, where 
an ovum is fertilized and then undergoes a continuous process involving successive mitosis, 
reaching an undifferentiated state called morula. The morula travels to the uterus, where it 
begins absorpting uterine fluid, forming a central cavity. At this point it is known as 
blastocyst. The blastocyst consists of a peripheral layer – the trophoblast – and a central 
lumen, known as inner cell mass or blastocyst cavity (Fig. 1).  
 
 
 
 
 
 
 
 
 
It then undergoes other important stages, namely implantation, placenta formation and 
organogenesis (4, 5). 
Along with the maternal contribution, it is from the trophoblast that the placenta arises, while 
the embryo develops from the inner cell mass. The trophoblast develops into two layers: an 
inner layer called cytotrophoblast, which remains as a single layer of cells, and an outer layer, 
called syncytiotrophoblast cells, resulting from the fusion of cytotrophoblast cells to form a 
continuous multinucleated syncytium that becomes increasingly broad and develops finger-
like projections into the endometrium. There is also a third layer, the intermediate 
trophoblast, that, like the name suggests, is found between the two previously mentioned 
layers, and which has an importance role in invading the endometrium (4). 
 
Figure 1: The several phases of the embryo in the first week of gestation 
(3)
. 
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The basal membrane of the cytotrophoblast, which lacks microvilli projections, becomes the 
basal membrane of the placenta, facing the fetal circulation, while the apical side of the 
syncytiotrophoblast becomes the apical membrane of the placenta, a microvillous brush 
border membrane that constitutes the mother-facing plasma membrane (Fig. 2) (6). Invasion 
of the intermediate trophoblast causes endometrial capillaries leakage resulting in the 
invasion of maternal blood into the lacunae, a network of spaces that will subsequentially 
allow the exchange of substances between the mother and the fetus (Fig. 3) (4). 
 
 
 
 
 
 
 
 
The sum of all these layers constitutes the placenta, a temporary organ that allows the 
exchange of nutrients, gases and other metabolites between the mother and the fetus (7). The 
Figure 2: Stages in the formation of a chorionic villus, starting with a cytotrophoblastic clump at 
the far left and progressing over time to an anchoring villus at right 
(4)
. 
Figure 3: Structure and circulation of the mature human placenta. Blood enters the intervillous 
spaces from the open ends of the uterine spiral arteries. After bathing the villi, the blood (blue) is 
drained via endometrial veins 
(4)
. 
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human placenta is classified as hemochorial because the fetal tissue is in direct contact with 
maternal blood existing, therefore, a juxtaposition of maternal and fetal circulations, without 
ever mixing the two (5, 8).   
In early pregnancy stages, the placenta mediates embryo implantation into the uterus and 
produces hormones that prevent the end of the ovarian cycle. Once the embryo’s 
implantation stage is succeeded, the placenta embraces many other important functions, 
being a crucial one the exchange of substances between the mother and the embryo that 
allow the latter to develop properly (9). 
The degree of exchange surface is enlarged at the placenta membranes due to the presence of 
microvilli. The presence of mitochondria, ribosomes, pinocytotic vacuoles and lipid 
enclosures has also been shown, reinforcing the belief of intense functional activity of 
exchange and synthesis, at this surface (10). 
The placental barrier is formed by cells that are interconnected by tight junctions, adherent 
junctions and desmosomes forming junctional complexes in a continuous line, regulating 
paracellular permeability and preventing the passage of macromolecules between the apical 
and basal cells poles. The frequency, position and dimensions of tight junctions are similar in 
all vessels, but seem to have different expression degrees (8). These structural properties 
insure controlled passage of different substances.  
The compounds can cross the cellular membranes via classical passive (facilitated diffusion, 
filtration, etc.) or active (carrier-mediated transport, endocytosis, etc.) transport systems (10). 
In the case of simple diffusion, the transfer occurs without energy use and is dependent on 
the concentration gradient between maternal and fetal blood. Regarding facilitated diffusion, 
it is carrier-mediated but not dependent on energy. The transfer occurs down the 
concentration gradient, is inhibitable by structural analogs and is saturable (11). There is also 
active transport, where the transfer occurs against an electrochemical or concentration 
gradient, requiring energy. It is, like facilitated diffusion, carrier-mediated, saturable, with 
possible competition between related molecules. There is also, in a minor scale, the transport 
of substances through endocytosis (phagocytosis or pinocytosis) and exocytosis, although it 
is probably the least understood transport process to date (11, 12). Whether the case, it is a 
controlled traffic assured by specific membrane proteins. These systems include plasma 
membrane carriers such as ABC (ATP-Binding Cassette) transporters and members of the 
SLC (Solute Carrier) family (5, 6). 
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The placenta also uses all these transporters as a mechanism, protecting the fetus from 
potentially harmful substances (Fig. 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Despite this selectivity, the placenta is considered a highly permeable organ for a significant 
amount of substances (6) and has a major role in the transfer of nutrients that support 
embryonic and fetal growth and development (Fig. 5), as well as in the synthesis of several 
compounds, like proteins, hormones and other regulatory factors, that provide all the 
necessary conditions to insure all pregnancy processes (6, 9, 10). Indeed, the placenta, and 
particularly the syncytiotrophoblast, is a very important endocrine organ, producing steroid 
hormones, like human chorionic gonadotropin (HCG), responsible for progesterone and 
estrogen production, chorionic somatomammotropin, and enzymes with critical role in 
hormones synthesis like 3β-hydroxysteroid dehydrogenase, aromatase and 17β-
hydroxysteroid dehydrogenase, as well as human placental lactogen and small amounts of 
Figure 4: Three levels of protection involved in the human placental barrier for drugs 
(6)
. 
C: Potentially bidirectional carriers. P: Export pumps. E: Metabolizing enzymes. D: Drug/Substrate. 
M: Drug/Substrate metabolite 
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chorionic thyrotropin and chorionic corticotropin. It also contains phase II enzymes like 
glutathione S-transferase α and π, epoxide hydrolase, N-acetyltransferase and 
sulfotransferases isoforms. (6, 9, 13)  
 
 
 
 
 
 
 
 
 
 
 
It is also important to refer that as pregnancy progresses, the placental membranes change in 
composition and size, as well as the ability of certain substances to cross the placenta (5, 6). 
Also, the membranes become thinner as pregnancy progresses, primarily due to partial 
disappearance of the cytotrophoblast. Despite this, in the human placenta, by the end of 
gestation the intensity of exchange decreases because of fibrinoid deposition on the exchange 
surface (9, 10). 
 
 
 
Figure 5: Placental exchange of substances between the mother 
and the fetus. 
(4)
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9.2 Glucose transport at the placenta 
Glucose is the primary and fundamental source of energy to all animal cells. As such, it is 
crucial that a proper amount of this hexose reaches the fetus, which has a significant absence 
of self-gluconeogenesis and, therefore, highly depends on the transplacental transfer of 
glucose from the mother (14-17). The possible implications of deficient glucose quantities are 
mentioned later on in Introduction. 
The maternal-fetal glucose transfer is regulated by several factors: glucose supply, placental 
glucose metabolism and placental glucose transporter density and activity. Glucose supply is 
determined by glucose concentration and blood flow. Glucose transfer across placenta barrier 
(intermembranous space) is a relatively rapid process compared to either the glucose supply 
or removal of glucose from the apical or basolateral membranes, respectively. Also, glucose 
transfer can be defined as a flow-limited phenomenon or, in other words, is limited by 
movement to and from the transfer site (16). 
The supply of glucose by the placenta depends mainly on a facilitated diffusion transport 
mechanism and is regulated by a relatively complex set of mechanism that tends to keep its 
metabolism relatively constant (14, 15, 17-20). Investigations reported back to the 80’s decade 
have already proven the presence of Na+- independent transporters belonging to a family of 
glucose transport proteins with similar kinetic characteristics – the GLUT family, a group of at 
least 12 isoforms (GLUT1 – GLUT12) of integral, transmembranar proteins, belonging to the 
group of solute carriers (SLCs) that gather a few common structural and metabolic 
characteristics: the presence of 12 membrane-spanning helices,  seven conserved glycine 
residues in the helices, several basic and acidic residues at the intracellular surface of the 
proteins, two conserved L-tryptophan residues, two conserved L-tyrosine residues, 
selectivity for D- over L-glucose and sensitivity to inhibition by phloretin and cytochalasin B 
(21-26). 
GLUT1 is considered the major glucose transporter isoform at the human placenta and also 
plays an important role in mediating implantation of the embryo. It is a membrane spanning 
glycoprotein containing 12 transmembranar domains with a single N – glycosylation site and 
its gene, SLC2A, is located on chromosome 1 ( 1p35 – 31.1). It has a catalytic turnover of 
~1200/s and provides an efficient pathway for cellular import and export of glucose (19).  It is 
found at both the maternal - facing microvillus trophoblast membrane and the fetal – facing 
basal trophoblast membrane, with an approximately three-fold higher quantity in the 
microvillus membrane, compared to the basal (14-16, 23). Also, the 6-fold larger surface area of 
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the microvillous covering leads to several times higher total transport capacity across the 
syncytial compared to the basal membrane. (14) For this reason, placental glucose transport is 
called “asymmetric”, since the maximal velocity (vmax) for sugar exit into sugar-free medium 
is not identical to the vmax for sugar entry into sugar-free cells.  
This asymmetry has led to an important insight: the hypothesis that the basal membrane is 
the rate limiting step in transsyncytial transport of glucose (16). Plus, studies have shown that 
the expression of GLUT1 in abnormal conditions is altered. More specifically, in diabetic 
human placenta, GLUT1 levels are increased while in intrauterine growth restriction GLUT1 
levels are decreased (18, 19). There are presently no specific GLUT1 inhibitors known. However, 
the inhibitors known for the GLUT family, cytochalasin B and phloretin, seem to be consider 
quite efficient, suggesting that GLUT1 ligand binding is compatible with a fixed site transport 
mechanism. In this type of mechanism, a ligand such as cytochalasin B that binds close to the 
endofacial sugar binding site does not eliminate the exofacial sugar binding site, unless 
occupancy of the endofacial binding site by the inhibitor reduces greatly the affinity of the 
exofacial site for glucose (Fig. 7) (19, 23, 27).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Molecular structure of D-Glucose (A), cytochalasin B (B) and phloretin (C), respectively 
(2)
. 
A B C 
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Although GLUT1´s expression has been established as the principal mediator of placental 
glucose transport, several studies investigated if other isoforms are also present at the 
human placental tissues and their role.  These studies showed that GLUT3, GLUT4, GLUT9 
and GLUT12 appear to be expressed at some extent (15, 16, 19, 22, 27-30).  
GLUT4 is an insulin-sensitive isoform and has been reported as being present in Jar 
choriocarcinoma cells but at levels so low that an insignificant contribution to cellular glucose 
uptake was suggested (16). Also, this isoform has not been identified in membranes from 
primary cultured syncytiotrophoblasts or cytotrophoblasts; so, it is unlikely that GLUT4 
contributes for trophoblast glucose uptake in vivo (16). In a study conducted by Araújo et al, in 
BeWo cells,  uptake of an analogue of glucose was shown to be insulin-independent, which 
indicates that, even if present, GLUT4 probably has a minor role, if any, in glucose uptake at 
the placenta (27). 
GLUT12 exhibits 29% homology with GLUT4 and, for that reason, it has been postulated that 
GLUT12 could be a second insulin-sensitive glucose transport system. Studies support the 
hypothesis that GLUT12 acts to facilitate glucose transport in vivo and its expression in 
Figure 7: Representation of GLUT1’s interface with substrates and inhibitors 
(1)
. 
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human placenta has been demonstrated by RT-PCR and Western blotting (28). However, its 
immunoreactivity seems to be predominantly expressed in the syncytiotrophoblast and 
extravillous trophoblast at the first trimester of gestation, and GLUT12 does not seem to be 
found at syncytiotrophoblasts at term (28).  
GLUT9 is a relatively recently cloned member of the GLUT family, and has been shown to 
exist as 2 splice variants, GLUT9a and GLUT9b, each with different targets at the membrane 
(30). The placenta is one of the few tissues that express both variants at the mRNA level, 
suggesting a possible role for both GLUT9a and GLUT9b in placental hexose transport. GLUT9 
transports both glucose and fructose but with close to 3-fold higher affinity for glucose (30). 
Concerning GLUT3, studies are somehow contradictory, namely in relation to tissues in which 
it is expressed, as well as its levels of expression. Collectively, the results show that, although 
GLUT3 mRNA is distributed throughout villous tissue, GLUT3 protein appears to be 
expressed in vascular endothelium, and it is still not clear if GLUT3 protein is expressed at the 
syncytiotrophoblast layer. Some recent studies affirm that GLUT3 is indeed present at the 
syncytiotrophoblast layer but mainly during first trimester. Also, GLUT3 has been reported to 
be a GLUT isoform with a higher affinity for glucose than GLUT1. So, GLUT3 could have an 
important part in the glucose uptake by the fetus in circumstances associated with a decrease 
in glucose concentration. Interestingly, GLUT3 mRNA levels seem to be altered under certain 
stimuli, such as hipoxia (15, 19, 22, 29). 
 
 
 
 
GLUT 
isoform 
Protein mRNA 
GLUT1 Syncytiotrophoblast, cytotrophoblast, 
endothelium, vascular smooth muscle, 
stromal cells 
Syncytiotrophoblast, cytotrophoblast, endothelium, vascular 
smooth muscle, stromal cells 
GLUT3 First trimester: extravillous trophoblast, 
cytotrophoblast 
Third trimester: endothelium 
First trimester: unclear 
Third trimester: syncytiotrophoblast, cytotrophoblast, 
endothelium 
GLUT4 Stromal cells Stromal cells 
GLUT9 At term: GLUT9a: basolateral membrane 
of the  syncytiotrophoblast  
At term: GLUT9b:  microvillous 
membrane 
At term: GLUT9a: basolateral membrane of the  
syncytiotrophoblast  
At term: GLUT9b:  microvillous membrane 
GLUT12 First trimester: extravillous trophoblast, 
cytotrophoblast, syncytiotrophoblast  
Third trimester: vascular smooth muscle, 
stromal cells 
First trimester: extravillous trophoblast, cytotrophoblast, 
syncytiotrophoblast  
Third trimester: vascular smooth muscle, stromal cells 
Table 1: Main glucose transporter isoform distribution at the human placenta   (16, 31) 
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9.3 Oxidative stress at the placenta and Antioxidants 
Oxidative stress is the term used to designate an imbalance between reactive oxygen species 
(ROS) and antioxidant levels in a cell, favoring the former (2, 31-33). At homeostatic levels, ROS 
are implicated in diverse actions on cell function, like activation of redox-sensitive 
transcription factors and activation of protein kinases (2), regulation of vascular tone and 
functions controlled by O2 concentrations, enhancement of signal transduction from many 
membrane receptors, like the antigen receptor of lymphocytes (32), among others.  
 
 
 
 
 
 
 
 
 
 
 
 
However, when in excess, ROS can induce cell injury and a chronic inflammatory state that 
can trigger a cascade of free radical reactions, promoting secondary ROS generation and 
resulting in cellular modification and damage in DNA, carbohydrates, proteins and 
polyunsaturated fatty acids (Table 2). 
 
                           Table 2: Some common biomarkers of oxidative stress used in the study of human diseases (38) 
Figure 8: Mechanisms of redox homeostasis. Balance between ROS production and 
various types of scavengers. The steady-state levels of ROS are determined by the rate 
of ROS production and their clearance by scavenging mechanisms 
(8)
. 
Introduction 
29 
 
Table 2: Some common biomarkers of oxidative stress used in the study of 
human diseases (34)  
DNA Aldehyde/other base adducts 
Nitrated/deaminated bases 
Oxidized bases 
Lipids Chlorinated/nitrated lipids (isoprostanes, 
isoleukotrienes) 
Oxysterols (aldehyde) 
Peroxides (malondialdehyde, 4-hydroxy-2-nonenal, 
acrolein) 
Proteins Aldehyde adducts 
Carbonyl group formation 
Nitrated/chlorinated Tyr, Trp, Phe 
Oxidized Tyr, Trp, His, Met, Lys, Leu, Ileu, Val 
Protein peroxides/hydroxides 
SH (thiol) oxidation 
 
This oxidative injury follows a general pattern that involves free thiol oxidation and 
formation of disulphide proteins, depletion of the ATP pool, free cytosolic Ca2+ increment, 
disintegration of cytoskeleton, increased membrane peroxidation, release of cytosolic 
compounds and DNA damage (33, 35). Examples of conditions associated with increase 
oxidative state include cellular aging, brain dysfunction and neurodegenerative diseases, 
atherosclerosis, cancer, diabetes, rheumatoid arthritis and cardiovascular and renal diseases 
(32, 36-38). 
Reactive oxygen species include free radical intermediates, such as the superoxide anion 
radical O2• ‒ (under physiological conditions it is the most common (2)), hydroxyl radical HO•, 
peroxyl radical ROO•, alkoxyl radical RO• and hydroperoxyl radical HO•2, and also non-radical 
intermediates, such as hydrogen peroxide (H2O2), ozone (O3), hypochlorous acid (HOCl), 
peroxynitrite (ONOO-) and singlet oxygen (1O2), with high instability due to the existence of 
one, or more, unpaired electrons (34, 35, 38). ROS can be generated from multiple mechanisms, 
such as:  
 Normal metabolic reactions, such as redox reactions during cell respiration. The 
oxygen’s reduction to water implies a 1-2% electron leakage, generating O2• ‒ at the 
ubiquinone and NADH dehydrogenase (complex I), as well in complex III; 
 Radiation, exciting UV rays and ionizing X rays; 
 Xenobiotics and drug metabolism;  
 The activity of monoamine oxidase, which deaminates biogenic amines. This 
mechanism occurs at the outer membrane of the mitochondria, and is associated to 
large H2O2 production;  
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 In purines catabolism and formation of uric acid, by xanthine oxidase, a superoxide 
producing enzyme; 
 During an inflammatory response, the production of H2O2 and O2• ‒ increases greatly 
in cells like polymorphonuclear cells, eosinophils, monocytes, Kupffer cells and 
macrophages, thanks to a highly specialized NADPH-dependent oxidase system 
located in the outer surface of cell membrane, coupled to the action of superoxide 
dismutase (SOD) (2, 39).  
 In the endoplasmic reticulum (ER), where a significant amount of superoxide is 
formed, during protein folding. In this process, the formation of disulphide bonds is 
an oxidative process, since it is due to the oxidation of sulphydryl groups of cysteine 
residues (2, 39, 40).  
At the placenta, ROS also seem to have important roles. During placental development, 
oxygen levels are relatively low, due the unfully established maternal intraplacental 
circulation, which is believed to be the reason why the embryo is particularly protected from 
oxygen free radicals at that time. These low levels are essential for normal placental 
angiogenesis, promoted by hypoxia-induced transcriptional and post-transcriptional 
regulation of angiogenic factors, like the vascular endothelial growth factor and placental 
growth factor (41). Once the maternal intraplacental circulation is fully formed (towards the 
end of the first trimester) the O2 concentration triplicates and, with it, so does ROS levels, 
particularly at the syncytiotrophoblastic layer (2, 42). Also, the placental itself is a source of ROS 
(43).  
Besides their inherent instability, ROS have a very short half-life (seconds) because of the 
efficiency of the antioxidant defense of the cells.  
Antioxidants are substances that, at relatively low concentrations, compete with other 
substrates susceptible to oxidation, delaying or inhibiting the oxidation of these substrates. 
They are, therefore, one of the cells’ defense mechanisms against ROS (32, 38). There are 
enzymatic and non-enzymatic antioxidants (2). Enzymatic antioxidants comprehend proteins 
that have a transitional metal in their core, capable of different valence states as they transfer 
electrons during the detoxification process (2). Antioxidant enzymes play a very important 
role in the response of trophoblasts to the significant increase in oxidative stress levels 
resulting from the perfusion of the intervillous space with maternal blood (41). Examples of 
these compounds are glutathione peroxidase, glutathione catalase and two isoforms of 
superoxide dismutase (SOD), the manganese form, which is present in the mitochondria, and 
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the copper and zinc form, present in the cytosol. These two forms convert superoxide to 
hydrogen peroxide that is then broken down to water by catalase or glutathione peroxidases. 
1-Cys peroxiredoxin (peroxiredoxin 6), peroxiredoxin 2 (thioredoxin peroxidase) and 
peroxiredoxin 1 (thioredoxin peroxidase 2) are also associated with several biological 
processes, among them oxidants detoxification (2, 32, 38, 41, 44-46).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-enzymatic defenses include thiol compounds (glutathione (GSH)), lipoic acid, 
thioredoxin that needs thioredoxin redutase to be converted back to its reduced form) and 
ceruloplasmin and transferrin, that by sequestering free iron ions inhibit Fenton reactions 
and the production of OH•. It is, however, important to refer that all of these compounds have 
Figure 9: Major pathways of ROS generation and metabolism. Superoxide can be generated by 
specialized enzymes, such as the xanthine or NADPH oxidases, or as a byproduct of cellular 
metabolism, particularly the mitochondrial electron transport chain. Superoxide dismutase 
(SOD), both Cu/Zn and Mn SOD, then converts the superoxide to hydrogen peroxide (H2O2) 
which has to be rapidly removed from the system. This is generally achieved by catalase or 
peroxidases, such as the selenium-dependent glutathione peroxidases (GPx) which use 
reduced glutathione (GSH) as the electron donor 
(3)
. 
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low specific antioxidant activity (on a molar basis) but greatly contribute to the overall ROS 
scavenging activity when present in high concentrations (2, 32, 38, 45, 47).  
Besides the antioxidants already mentioned, there are many other compounds that provide 
beneficial outcomes and can be found in food and nutritional supplements. 
Ascorbic acid (vitamin C) and α-tocopherol (vitamin E), for example, are two vitamins that act 
in concert, with the first being necessary to the regeneration of the reduced form of the latter, 
which is why this is called an antioxidant network (Fig. 10). Vitamin C, or ascorbic acid, is an 
essential water-soluble vitamin widely found in fruit and vegetables and has important roles 
in collagen synthesis, wound healing and prevention of anaemia, besides its importance in 
ROS scavenging. α-Tocopherol is a lipid-soluble vitamin that acts at lipid membranes. Because 
it possesses an hydrophobic tail, it tends to accumulate within the interior of lipid 
membranes, acting as an important chain-breaker, as it reacts with lipid peroxyl radicals 
about four times faster than they can react with adjacent fatty acid side chains constituting, in 
this way, a crucial defense against ROS at biological membranes (2, 48). Besides the antioxidant 
properties, vitamin E presents other effects, due to specific interactions with enzymes or 
transcription and specifically enhances the effect of ascorbic acid on cells (48). It is found in 
cereals and seed oil (3). 
 
 
 
 
 
 
 
 
 
Resveratrol, quercetin, epigallocatechin-3-gallate, β-carotene and N-acetylcysteine are other 
examples of natural antioxidants (27, 34, 35, 47). The first three belong to a class of compounds 
Figure 10: Synergistic mechanisms of vitamin C (ascorbic acid) and vitamin E (α-
tocopherol) to prevent lipid peroxidation by O2• (oxygen free radical) 
(7)
. 
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called polyphenols, which constitute one of the most numerous and widely distributed 
groups in the plant kingdom. Polyphenols are products of secondary metabolism of plants 
and, chemically, they are characterized by containing, linked to a benzoic ring, at least two 
hydroxyl groups. According to the number of phenolic groups contained or the structural 
elements that bind the rings to one another, polyphenols can be divided into at least ten 
classes (49). Their antioxidant character provides a vast metabolic activity and they have been 
related to decrease in cardiovascular disease and atherosclerosis, the risk of Alzheimer’s 
disease development and even in prevention of some cancers, as well as in cellular aging 
delay (50, 51).  
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9.4 The project 
Nutrition during early development is associated with proper offspring’s growth, organ 
development, body composition and body functions. It also implicates long-term effects on 
health and morbidity and mortality risk in adulthood, as well as on the development of neural 
functions and behavior, a phenomenon called ‘metabolic programming’ (52). The response of 
the fetus to the environmental insults during the prenatal period is associated with increased 
susceptibility of the offspring to cardiovascular diseases, metabolic syndrome, hypertension, 
type II diabetes and obesity (53, 54).  
So, it becomes fundamental to understand which conditions modulate the placental uptake of 
critical nutrients such as glucose. For example, although the fetus is known to have 
considerable capacity to metabolically adapt to acute and chronic changes in glucose supply, 
lower or higher maternal blood glucose levels can lead to alterations in fetal growth and 
weight (55). Also, previous studies from the group showed that several bioactive compounds, 
as well as some drugs of abuse, may modulate the apical uptake of glucose at the placenta (27, 
56). According to several studies, ABC and SLC transporters are able to transport not only 
nutrients but also drugs and xenobiotics, which mean that the xenobiotics may compete with 
the physiological substrates of the placental transporters and interfere with the delivery of 
nutrients such as glucose to the fetus (6, 9). And, as gestation progresses, there is a higher 
possibility for xenobiotics, among other substrates, to enter fetal tissues leading to potential 
effects on fetal development because cytochromes P450 like CYP1, CYP2 and CYP3, 
responsible for the detoxification of drugs and toxins, tend to decline in expression and 
activity from the first trimester to the second and third trimesters (5, 6). Another important 
fact is that some compounds may enter the placenta and be then metabolized into toxic 
substrates leading also to possible negative implications to a proper fetal development. It has 
also been proven that several drugs of abuse influence the perfusion pressure of the placenta 
(10).  
As pregnancy progresses, morphological and biochemical alterations take place at the 
placenta, as already mentioned. One of the most significant changes is oxygen levels. Initially, 
the placenta develops at a low oxygen environment, with a pressure around 20 mmHg (41). 
This favors cell proliferation and angiogenesis in the placenta and organogenesis in the 
embryo. Once the intervillous circulation is established, the oxygen tension rises. The 
placenta then adapts to this increase by modulating hypoxia-inducible factor 1α (HIF-1α) and 
increasing cellular antioxidants levels (41). Under normal conditions, this adaptation is 
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favorable to fetal development. For example, some studies suggest that NAD(P)H oxidase can 
act as an “oxygen sensor”, regulating differentiation from cytotrophoblast to 
syncytiotrophoblast when oxygen tension increases, or that VEGF-A (vascular endothelial 
growth factor A) and metalloproteins are sensitive to oxidative stress. Also, superoxide 
activates cytokine synthesis and, therefore, may play a role in maternal inflammatory state 
that characterizes normal pregnancy (47). So, it is understandable that aberrations in these 
modifications and adaptations predisposes placental villi to high oxygen tension, hypoxia, 
hypoxia-reoxygenation and mechanical injury in all different stages of the pregnancy, all of 
which are implicated in pregnancy complications (41).   
Several studies have been conducted for the last two decades that relate increased oxidative 
stress levels to several pregnancy pathologies, including spontaneous abortion, idiopathic 
recurrent pregnancy loss, defective embryogenesis, drug-induced teratogenicity, 
preeclampsia, intrauterine growth restriction and minor congenital abnormalities, as well as 
to future diseases in adulthood, such as obesity, diabetes mellitus and hypertension (32, 40-43, 57-
59). For example, preeclampsia by itself is a state of oxidative stress, with several studies 
reporting a decrease of placental antioxidant capacity and an increase in the source of ROS in 
a preeclamptic placenta, which is likely to be a combination of increased mitochondrial 
generation and synthesis through xanthine oxidase and NAD(P)H oxidase (47).  Another 
example is fetal growth restriction, which is recognized as a major cause of perinatal 
morbidity and mortality.  
From the preceding description, it can be seen that oxidative stress may induce a wide range 
of cellular responses depending upon the severity of the insult and the compartment in which 
the ROS are generated. Some of the more major signaling pathways involved and potential 
outcomes are presented in Fig. 11. 
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Besides the increase in placental concentration of ROS due to placental metabolism, pregnant 
women can be exposed to environmental oxidative stress inducers, as a part of their lifestyle 
or diet, smoking, drugs and alcohol consumption. In biochemical terms, this represents an 
even more accentuated increase of ROS levels. As already mentioned, excessive ROS levels are 
usually synonymous of increased health risk for the mother and the fetus. 
So, knowledge on the placenta’s dynamics becomes fundamental, in order to understand 
which conditions and substrates, or lack of such, can imply a pathological risk to the fetus. 
With this in mind and taking that very little is known about the subject, the purpose of this 
study was to find out if the uptake of glucose, the fetus’ primary source of energy, would be 
compromised under oxidative stress conditions. For such, a proper cellular model 
representative of the human placenta dynamics was necessary and the BeWo cell line was 
chosen. 
BeWo cells derive from a human choriocarcinoma and are a trophoblastic cell line that forms 
a confluent and consistent monolayer. This is an essential condition to investigate the 
processes of regulation/distribution of several compounds between maternal and fetal 
compartments.  BeWo are stable, i.e., have low spontaneous fusion rate, are relatively easy to 
maintain by passage, grow into confluent monolayer, with regular microvilli on the apical 
surface, in a short period of time (about 5 to 7 days) and own the important feature of 
displaying morphological properties and biochemical marker enzymes that are common to 
Figure 11: How reactive oxygen species may be generated within the syncytiotrophoblast, 
and the main consequences for the function of the tissue. CHOP (C/EBP homologous 
protein); NADP (nicotinamide adenine dinucleotide phosphate); ROS (reactive oxygen 
species); UPR (unfolded protein response) 
(2)
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the normal trophoblats. Also, they exhibit polarized transcellular transport of transferrin, 
serotonin and monoamine uptake systems and, when treated with adenosine 3’,5’-cyclic 
monophosphate or forskolin, differentiate and exhibit morphological characteristics similar 
to the fusion of cytotrophoblasts into a syncytia in primary culture (20, 60, 61). For all these 
reasons, BeWo is the most extensively used cell cellular model for villous trophoblasts 
investigations (60), including analysis of hypoxia-induced responses in the syncytialization of 
human placenta (44), studies on syncytial fusion and expression of syncytium-specific proteins 
(62), studies on transport of xenobiotics and drugs of abuse (27), evaluation of therapeutic 
agents (60, 61), studies on the link between certain compounds and some pregnancy 
pathologies, among many others. BeWo cells constitute an excellent alternative for human 
cytotrophoblasts because the latter tend to spontaneously differentiate into 
syncytiotrophoblasts, but not forming the needed confluent and consistent monolayer for 
transcellular transport processes (20, 60).  
In order to study the effect of oxidative stress upon glucose uptake, tert-butylhydroperoxide 
(tBOOH; C4H10O2) was used. tBOOH is an oxidant organic compound that can access biological 
membranes and has been extensively used as an oxidative stress inducer in a variety of 
systems (63). The genotoxicity of this compound increases due to reactions related to 
transition metals, resulting in the formation of different ROS, including H2O2 (35, 63). Among 
proposed mechanisms of action for tBOOH, homeostatic alteration of intracellular Ca2+, 
followed by depletion of glutathiones and proteins with thiol groups, breakdown of DNA 
chains, lipid peroxidation and production of tert-butoxil radicals have been referred (35, 64).  
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The purpose of this project was to investigate, using the BeWo cell line, the effect of oxidative 
stress upon the absorption of glucose at the placenta. For that, the inherent objectives were: 
1. To quantify some oxidative stress biomarkers, in BeWo cells, after exposure to 
increasing concentrations of tert-butylhydroperoxide (tBOOH) for 24h: 
1.1. Total glutathione (GSx), oxidized glutathione (GSSG) and reduced glutathione 
(GSH) levels; 
1.2. Lipid peroxidation; 
1.3. Carbonylated proteins; 
2. To evaluate cellular integrity, in BeWo cells, after exposure to increasing 
concentrations of tBOOH for 24h; 
2.1.  Cellular viability; 
2.2.  Cellular proliferation; 
3. To quantify 3H-2-D-glucose (3H-DG) uptake, by BeWo cells, after 24h of exposure to 
tBOOH at the concentration chosen as optimal to induce stress, taking points 1 and 2: 
3.1. To evaluate the time-course of 3H-DG uptake; 
3.2. To evaluate the kinetics of uptake, Km and Vmax; 
3.3. To evaluate the pharmacological characteristics, by using specific inhibitors; 
4. To quantify the mRNA levels of the glucose selective transporter GLUT1, by qRT-PCR, 
in BeWo cells after 24h of exposure to tBOOH at the concentration chosen as optimal 
to induce stress, taking points 1 and 2. 
5. To quantify lactate levels, in BeWo cells, after 24h of exposure to tBOOH at the 
concentration chosen as optimal to induce stress, taking points 1 and 2. 
6. To quantify 3H-2-D-glucose (3H-DG) apical-to-basolateral transepithelial transport 
across BeWo cells, after 24h of exposure to tBOOH at the concentration chosen as 
optimal to induce stress, taking points 1 and 2. 
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11.1 Materials  
2-[1,2-3H(N)]-deoxy-D-glucose - specific activity 60 mCi/mmol (American Radiolabeled 
Chemicals, St. Louis, MO, USA); BSA (albumin from bovine serum), acetic acid sodium salt, 
chelerythrine chloride, collagen type I, cytochalasin B (from Diechslera dematioidea), decane, 
DTNB (5,5’-dithiobis(nitrobenzoic) acid), DNP (2,4-dinitrophenylhydrazine), EGCG [(–) 
epigallocatechin-3-gallate], FCS (fetal calf serum), GSH reductase, Ham’s F12K medium 
(Kaighn’s modification), guanidine hydrochloride, LY-294002 hydrochloride (2-(4-
Morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride), NAC (N-acetyl-L-cysteine), 
NADPH (β-nicotinamide adenine dinucleotide 2′-phosphate reduced tetrasodium salt 
hydrate), NADH (β-Nicotinamide adenine dinucleotide, reduced disodium salt hydrate), 
quercetin dihydrate, phloretin, resveratrol, sodium pyruvate, phenol red sodium salt, 
sulforhodamine B, tBOOH (tert-butylhydroperoxide solution) 2-thiobarbituric acid, 
trichloroacetic acid sodium salt, Tris-HCl and 2-vinylpyridine (Sigma, St. Louis, MO, USA); 
D(+)-glucose, DMSO (dimethylsulfoxide), ethylacetate, perchloric acid and Triton X-100 
(Merck, Darmstadt, Germany); ethanol (Panreac, Barcelona, Spain). 
The drugs to be tested were dissolved in water, decane, methanol or DMSO. The final 
concentration of the solvents in the buffer and culture medium was 1% (v/v). 
 
11.2 Methods 
11.2.1 BeWo cell culture 
The BeWo cell line was obtained from the American Type Culture Collection (ATCC CCL-98, 
Rockville, MD, EUA) and was used between passage numbers 34 and 65. The cells were 
maintained in a humidified atmosphere of 5% CO2-95% air and were grown in Ham’s F12K 
Medium, containing 2.5 g/l sodium bicarbonate, 10% heat-inactivated fetal calf serum, and 
1% antibiotic/antimycotic solution.  Culture medium was changed every 2 to 3 days and the 
culture was split every 7 days. For sub-culturing, the cells were removed enzymatically 
(0.25% trypsin-EDTA, 5 min, 37 °C), split 1:3, and sub-cultured in plastic culture dishes (21 
cm2; Ø 60 mm; Corning Costar, Corning, NY, USA). For oxidative stress markers and transport 
studies, BeWo cells were seeded on collagen coated 12-well (3.6 cm2; Ø 21 mm; TPP®) or 24-
well (2 cm2; Ø 16 mm; TPP®) plastic cell culture clusters and were used after 5-7 days in 
culture (90-100% confluence). At that moment, each square centimeter contained about 60 
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µg cell proteins. For transepithelial transport studies, cells were seeded on collagen-coated 
Transwells  (1.12 cm2; Corning Costar, Corning, NY, USA) and were used after 8-10 days. 
 
11.2.2 Incubation of BeWo cells with tert-butylhydroperoxide (tBOOH) 
Before each experiment, the cell culture medium was removed and each well was incubated 
with serum free culture medium for 24h, at 37°C, in the absence or presence of tBOOH.  
 
11.2.3 Evaluation of tBOOH effect on cell integrity 
 
11.2.3.1 Cellular viability (quantification of extracellular LDH activity) 
Cells were seeded on 24-well plates and submitted to treatment with tBOOH (1, 3, 10, 30, 
100, 300 and 1000 μM). After treatment, cellular leakage of the cytosolic enzyme lactate 
dehydrogenase (LDH) into the extracellular medium was measured 
spectrophotometrically by measuring the decrease in absorbance of NADH during the 
reduction of pyruvate to lactate, as described by Bergmeyer and Bernt (65). 
11.2.3.2 Cellular proliferation (sulforhodamine B (SRB) assay) 
Cells were seeded on 24-well plates and submitted to treatment with tBOOH (1, 3, 10, 30, 
100, 300 and 1000 μM). After treatment, 62.5 µl of ice-cold 50% (w/v) TCA were added to 
the culture medium on each well to fix cells (1h at 4°C in the dark). The plates were then 
washed five times with tap water to remove TCA. Plates were air-dried and then stained 
for 15 min with 0.4% (w/v) SRB dissolved in 1% (v/v) acetic acid. SRB was removed and 
cultures were rinsed four times with 1% (v/v) acetic acid to remove residual dye. Plates 
were again air-dried and the bound dye was then solubilized with 375 µl of 10 mM 
Tris.NaOH solution (pH 10.5). The absorvance of each well was determined at 540 nm (66). 
 
Materials and Methods 
47 
 
11.2.4 Evaluation of tBOOH-induced oxidative stress 
The extent of oxidative stress induced by tBOOH was indirectly evaluated by measuring total 
(GSx), oxidized (GSSG) and reduced (GSH) glutathione levels, protein carbonyl groups and 
generation of lipid peroxidation products. 
 
11.2.4.1 Measurement of total (GSx), oxidized (GSSG) and reduced (GSH) 
glutathione levels 
Cells were seeded on 24-well plates and submitted to treatment with tBOOH (10, 30 and 
100 µM). Afterwards, measurements of intracellular GSx levels were carried out 
according to a previously published method (67). Briefly, cells were scraped and proteins 
precipitated with perchloric acid 5%, then centrifuged for 10 min at 4C and the 
supernatant was neutralized with an equimolar solution of KHCO3. GSx contents were 
measured by the rate of colorimetric change of 0.7 mM 5, 5-dithiobis (nitrobenzoic acid) 
at 415 nm in the presence of 0.4 U of GSH redutase and 0.24 mM NADPH, using a 
microplate reader. GSSG was also quantified, using 2-vinylpiridine to block free SH 
groups. GSH levels were calculated according to the following reaction: GSx = GSH + 2 
GSSG. 
11.2.4.2 Measurement of lipid peroxidation (TBARS assay) 
Cells were seeded on 12-well plates and submitted to treatment with tBOOH (10, 30 and 100 
µM). The extent of lipid peroxidation, determined as the formation of malondialdehyde 
occurring after the breakdown of polyunsaturated fatty acids, was measured by the 
thiobarbituric acid reactive substances (TBARS) assay. (70) Briefly, 300 µl of cell suspension 
was precipitated with 200 µl of 50% trichloroacetic acid (TCA) and centrifuged for 1 min at 
6000 rpm. 300 µl of the supernatant were added with equal volume of 1% thiobarbituric acid 
and the resulting mixture was heated during 40 min at 95°C. The absorvance was measured 
at 535 nm after the mixture was cooled. 
 
11.2.4.3 Measurement of carbonylated proteins 
Cells were seeded on 12-well plates and submitted to treatment with tBOOH (100 µM). 
Carbonyl (CO) groups (aldehydes and ketones) are produced on protein side chains when 
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they are oxidized. Protein carbonyl content is the most used marker of protein oxidation 
(50). Detection of protein carbonyl groups involves their reaction with 2,4-
dinitrophenylhydrazine (DNPH), which leads to the formation of a stable 2, 4-
dinitrophenyl (DNP) hydrazone product, followed by the spectrophotometric 
quantification of the acid hydrazones (72). Briefly, carbonyl content was measured in the 
resulted pellet that was treated with 0.5 ml of 2, 4-dinitrophenylhydrazine (10 mM in HCl 
2 M) or 0.5 ml of HCl 2 M for the blank. Samples were incubated for 1h at room 
temperature, vortexing every 10 min. 0.5 ml of TCA 20% was added to each tube which 
was allowed to stand for 15 min at 4°C. The resultant pellet was washed 3 times with 
ethanol-ethyl acetate (1:1), centrifuged at 13000 rpm for 2 min at 4°C and dissolved in 1 
ml guanidine 6 M overnight. The solution was then centrifuged at 3000 rpm for 15 min. 
Absorbance was read at 340 nm and carbonyl content was calculated using the extinction 
coefficient of 22 000 M−1 cm−1.  
 
11.2.5 Determination of 3H-2-deoxy-D-glucose (3H-DG) uptake 
Transport experiments were performed in glucose-free HEPES-buffered solution (GF-HBS) 
containing NaCl 140 mM, KCl 5 mM, CaCl2 1 mM, MgSO4 2.5 mM, HEPES 20 mM and pH 7.4.  
Initially, the culture medium was aspirated and the cells were washed with buffer at 37C; 
then the cell monolayers were pre-incubated for 20 min in buffer at 37C in the absence or 
presence of tBOOH and the testing compounds. Uptake was initiated by the addition of 0.2 ml 
buffer at 37C containing 50 nM 3H-DG, in the absence or presence of tBOOH and the testing 
compounds. Incubation was stopped after 120 min (except in the time-course experiments) 
by removing the incubation medium and rinsing the cells with 0.5 ml ice-cold buffer. The cells 
were then solubilized with 0.3 ml 0.1% (v/v) Triton X-100 (in 5mM Tris–HCl, pH 7.4), and 
placed at 4C overnight. Radioactivity in the cells was measured by liquid scintillation 
counting. 
 
11.2.6 Protein determination 
The protein content of cell monolayers was determined as described by Bradford method (68) 
using serum albumin as standard. 
 
Materials and Methods 
49 
 
11.2.7 Quantitative reverse transcription real-time-PCR (qRT-PCR) 
Total RNA was extracted from BeWo cells using the Tripure® isolation reagent, according to 
the manufacturer’s instructions (Roche Diagnostics, Germany). Before cDNA synthesis, total 
RNA was treated with DNase I (Invitrogen Corporation, CA, USA) according to manufacturer’s 
instructions, and 10 µg of resulting DNA-free RNA were reverse transcribed using Superscript 
Reverse Transcriptase II and random hexamer primers (Invitrogen Corporation) in 40 µl of 
final reaction volume, according to the manufacturer’s instructions. Resulting cDNA was 
treated with RNase H (Invitrogen Corporation) to degrade unreacted RNA. For the 
quantitative real-time PCR, 2 µl of the 40 µl reverse transcription reaction mixture were used. 
For the calibration curve, BeWo standard cDNA was diluted in five different concentrations. 
The primers pairs used for amplification were: 5’-GGT CAA GGT CGC AAG C-3’ (forward) and 
5’-GGG CAT ATC CTA CAA CAA ACT-3’ (reverse) for housekeeping hypoxanthine-guanine 
phosphoribosyltransferase (HPRT) and 5’- GAT GAT GCG GGA GAA GAA GGT-3’ (forward) and 
5’- ACA GCG TTGA TGC CAG ACA G-3’ (reverse) for facilitative glucose transporter 1 (GLUT1). 
Real-time PCR was carried out using a LightCycler (Roche, Nutley, NJ, USA). 20 µl reactions 
were set up in microcapillary tubes using 0.5 µM of each primer and 4 µl of SYBR Green 
master mix (LightCycler FastStart DNA MasterPlus SYBR Green I, Roche). Cycling conditions 
were as follows: denaturation (95°C for 5 min), amplification and quantification (95°C for 10 
s, annealing temperature (AT) for 15 s, and 72°C for 10 s, with a single fluorescence 
measurement at the end of the 72°C for 10 s segment) repeated 50 times, a melting curve 
program ((AT + 10)°C for 15 s and 95°C with a heating rate of 0.1°C/s and continuous 
fluorescence measurement), and a cooling step to 40°C (30 s). Annealing temperatures (AT) 
and sequence of primers are indicated in Table 1. Data were analyzed using LightCycler® 
4.05 analysis software (Roche, Mannheim, Germany). 
 
11.2.8  Lactate measurements 
Lactates measurements were based on the oxidation of L-lactate (final product in anaerobic 
glycolysis) to pyruvate and hydrogen peroxide by lactate oxidase. The enzyme peroxidase, in 
the presence of a hydrogen donor, converts hydrogen peroxide in water and, hence, the 4-
aminoantipirine in a collared product. This collared product, which concentration is 
proportional to the lactates concentration in the sample, is measured spectrophotometrically, 
according to the fabricants’ instructions.  
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11.2.9 Transepithelial Studies 
 Confluent BeWo cells were used for permeability studies. Cell monolayer integrity and 
confluence was assessed by measurement of transepithelial resistance (TEER) before the 
beginning of each experiment, by using an epithelial voltimeter fitted with planar electrodes 
(EVOM; World Precision Instruments, Stevenage, UK). Experiments were conducted only in 
those cell monolayers that showed a TEER >100 Ω, after correction for the resistance 
obtained in a Snapwell without cells. TEER was also determined after each experiment to 
determine the effect of test substances on monolayer integrity. 
Initially, the culture medium was aspirated and the cells were washed with buffer at 37C; 
then the cell monolayers were pre-incubated for 20 min in buffer at 37C in the absence or 
presence of tBOOH 100 μM. Uptake was initiated by the addition of 0.3 ml buffer at 37C 
containing 20 nM 3H-DG at the apical side, in the absence or presence of tBOOH μM. Samples 
from the basolateral side were collected every 30 min and incubation was stopped after 120 
min, by removing the incubation medium and rinsing the apical side with 0.5 ml ice-cold 
buffer and the basolateral side with 1.5 ml ice-cold buffer. The cells were then solubilized 
with 0.3 ml 0.1% (v/v) Triton X-100 in the apical side and with 0.5 ml in the basolateral side, 
and placed at 4C overnight. Radioactivity in the cells was measured by liquid scintillation 
counting and results were expressed as apparent permeability (Papp). 
 
11.2.10 Calculation and statistics 
For the analysis of the time course of 3H-DG uptake, the parameters of Equation 1 were fitted 
to the experimental data by a non-linear regression analysis, using a computer-assisted 
method (69). 
       (1) 
 
A(t) represents the accumulation of 3H-DG at time, kin and kout are the rate constants for 
inward and outward transport, respectively, and t is the incubation time. Amax corresponds to 
the accumulation (A(t)) at steady state (t→∞). kin is given in nmol per milligram protein per 
)1(/)(
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min and kout in min-1. In order to obtain clearance values, kin was converted to µl per 
milligram protein per min. 
For the analysis of the saturation curve of 3H-DG uptake, the parameters of the Michaelis-
Menten equation were fitted to the experimental data. 
Arithmetic means are given with SEM, and geometric means are given with 95% confidence 
limits. Statistical analysis of the difference between various groups was evaluated by the 
ANOVA test, followed by the Student-Newman-Keuls test. Statistical analysis of the difference 
between two groups was evaluated with Student’s t test. Differences were considered to be 
significant when P<0.05. 
Papp values were determined according to Equation 2 
 (2) 
where dQ/dt (moles per second) is the transport rate, Ci (moles per cubic centimeter) is the 
initial concentration in the donor chamber, and A (square centimeters) is the surface area. 
Arithmetic means are given with SEM, and geometric means are given with 95% confidence 
limits. Statistical analysis of the difference between various groups was evaluated by the 
ANOVA test, followed by the Student-Newman-Keuls test. Statistical analysis of the difference 
between two groups was evaluated with Student’s t test. Differences were considered to be 
significant when P<0.05. 
 
 
 
 
 
 
 
 
 
Papp = dQ/dt · 1/ (A · Ci) cm/s 
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12 Results 
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12.1 Effect of tBOOH on cell integrity and oxidative stress biomarkers 
The first step was to determine the proper concentration of tBOOH to use for inducing 
oxidative stress in BeWo cells, since our aim was to induce oxidative stress without 
compromising cell integrity. For that, BeWo cells were submitted to a 24h-treatment to 
increasing concentrations of tBOOH (1, 3, 10, 30, 100, 300 and 1000 μM), and the cell 
integrity, as well as some oxidative stress biomarkers, were evaluated. 
 
12.1.1 Cell integrity 
In order to assess cell integrity, the effect of tBOOH upon cellular viability and proliferation 
was evaluated. Exposure of BeWo cells to tBOOH 300 μM and 1000 μM caused an increase in 
LDH leakage, indicating that these concentrations did affect cell membrane integrity (Fig. 12 
left side). Similarly, treatment with tBOOH 300 μM and 1000 μM caused a significant decrease 
in BeWo cell proliferation (Fig.12 right side). 
  
 
 
 
 
 
 
 
 
 
Considering these results, some important biomarkers were then analyzed for tBOOH 10, 30 
and 100 μM, in order to evaluate oxidative stress levels. 
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Figure 12: Effect of tBOOH on cell viability (left panel) and cell proliferation (right panel). After a 24h-exposure to 
different concentrations of tBOOH (1-3000 µM) or its solvent (control), BeWo cellular viability was determined by 
quantification of extracellular LDH activity (n=9-12) and cellular proliferation was determined by quantification of 
whole cellular protein with SRB (n=9-12). Shown are arithmetic means ±S.E.M. *significantly different from control 
(P < 0.05). 
#
significantly different from tBOOH 1-100 μM  
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12.1.2 Oxidative stress biomarkers 
 
12.1.2.1 Glutathiones 
One of the biomarkers analysed were the cellular levels of total (GSx), oxidized (GSSG) and 
reduced (GSH) glutathione, as well as the GSH/GSSG ratio.  
BeWo cells were treated with tBOOH 10, 30 and 100 μM for 24h, and the results are 
presented in Fig. 13. As shown, levels of total glutathione (GSx) were significantly increased 
with tBOOH 30 and 100 μM. Moreover, levels of oxidized glutathione (GSSG) were increased 
with tBOOH 100 μM. As for reduced glutathione (GSH) levels, no significant changes were 
observed. 
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Figure 13: Effect of tBOOH on total (GSx), oxidized (GSSS) and reduced (GSH) glutathione levels. These parameters 
were determined after a 24h-exposure of BeWo cells to concentrations of tBOOH (10-100 µM) that did not affect 
neither cellular viability nor proliferation or to the respective solvent (control) (n=9-16). Shown are arithmetic 
means ±SEM. *significantly different from control (P < 0.05). 
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To further evaluate the effect of tBOOH upon oxidative stress levels, two other two 
biomarkers were also assessed.  
12.1.2.2 Lipidic peroxidation and carbonylated proteins 
The extent of lipid peroxidation was measured by using the TBARS assay. Lipid peroxidation 
results in the formation of reactive aldehydes, including malondialdehyde (MDA). The extent 
of protein carbonylation was evaluated by measuring protein carbonyl groups, which are 
produced on protein side chains when they are oxidized. tBOOH 100 μM caused a significant 
increase in MDA levels, indicating oxidative damage to cell lipids (Fig. 14, left side) and a 
significant increase in the concentration of carbonyl groups, indicating oxidative damage to 
proteins (Fig. 14, right side). 
 
 
 
  
 
 
 
 
 
 
 
12.2 Effect of tBOOH on 3H-2-D-glucose uptake 
12.2.1 Effect of tBOOH on total uptake 
In a first series of experiments, the time-course of 3H-DG (50 nM) accumulation in BeWo cells 
was determined. For this, cells were incubated at 37°C with 3H-DG for various periods of time, 
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Figure 14: Effect of tBOOH on MDA (lipid peroxidation product) and protein carbonyl levels in BeWo cells. These 
parameters were determined after a 24h-exposure of BeWo cells to concentrations of tBOOH (10-100 µM) that 
did not affect neither cellular viability nor proliferation or to the respective solvent (control) (n=15-30). Shown are 
arithmetic means ±SEM. *significantly different from control (P < 0.05).  
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(1, 5, 10, 30, 90 and 120 min), in the absence or presence of a previous treatment with 100 
μM tBOOH for 24h. As shown in Fig. 15, treatment with tBOOH originated a reduced 
accumulation of 3H-DG over time. Analysis of the time-course of 3H-DG accumulation showed 
a decrease of about 33% in the Amax in the presence of tBOOH. Also, both the kin and kout were 
significantly different between control and tBOOH (Table 3). Analysis of Table 3 shows that, 
in control conditions, an amount of cells corresponding to 1 mg of cell proteins removed the 
3H-DG present in 9.5 μL of buffer and that, simultaneously, 3% of intracellular 3H-DG left the 
cells per min. On the other hand, after treatment with tBOOH, an amount of cells 
corresponding to 1 mg removed the 3H-DG present in 16.1 μL of buffer and, simultaneously, 
8% of intracellular 3H-DG left the cells per minute. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Amax 
(pmol.mg prot-1) 
Kin 
(μL.mg prot-1.min-1) 
Kout 
(min-1) 
Control 15.4 ± 0.9 9.5 ± 1.5 0.03 ± 0.006 
tBOOH 10.4 ± 0.5* 16.1 ± 2.2* 0.08 ± 0.01* 
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Figure 15: Effect of tBOOH upon the time-course of 3H-DG apical uptake by 
BeWo cells. Cells were exposed for 24h to tBOOH 100 µM or the respective 
solvent (control). After that, cells were incubated in buffer with Na+ at pH 
7.4, containing 50 nM 
3
H-DG, for various periods of time (n=6-17). Shown 
are arithmetic means ±S.E.M. *significantly different from control (P < 0.05). 
Table 3: Analysis of the time course of 3H-DG apical uptake by BeWo cells. Cells 
were exposed for 24h to tBOOH 100 µM or the respective solvent (control). Analysis 
allowed determination of the steady state of accumulation (Amax) and the rate 
constant for inward (kin) and outward (kout) transport. Shown are arithmetic means 
±S.E.M. *significantly different from control (P < 0.05). 
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12.2.2 Effect of tBOOH on GLUT-dependent and GLUT-independent uptake 
At this point, it was important to characterize 3H-DG uptake in BeWo cells in both, normal 
conditions (control) and under oxidative stress conditions (tBOOH), by investigating how 
much of 3H-DG uptake was GLUT-mediated. In order to do so, a GLUT inhibitor (cytochalasin 
B 50 μM) was used. This compound was already used by the group to inhibit GLUT activity in 
the BeWo cell line. (27) The results show that cytochalasin B 50 μM inhibits about 50% of 3H-
DG uptake (Fig. 16). Also, both the kin and kout were significantly different between control 
and cytochalasin B (Table 4). Indeed, analysis of Table 4 shows that, in control conditions, an 
amount of cells corresponding to 1 mg of cell proteins removed the 3H-DG present in 9.5 μL of 
buffer and that, simultaneously, 3% of intracellular 3H-DG left the cells per min. On the other 
hand, after treatment with cytochalasin B, an amount of cells corresponding to 1 mg removed 
the 3H-DG present in 2.37 μL of buffer and, simultaneously, 1.6% of intracellular 3H-DG left 
the cells per minute. 
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Figure 16: Time-course of 3H-DG uptake by BeWo cells. Cells were 
incubated in buffer with Na+ (TOTAL, black curve) or in buffer without Na+ 
and in the presence of cytochalasin B 50 μM (Cyt B (non-GLUT mediated); 
grey curve) at pH 7.4, containing 50 nM 
3
H-DG, for various periods of time 
(n=6-17). *significantly different from control (P < 0.05).  
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Another commonly used GLUT inhibitor, phloretin (2 mM), was also simultaneously tested as 
a possibly more appropriate and effective GLUT inhibitor. 
The results, presented in Fig. 17, show that phloretin (2 mM) inhibited 3H-DG uptake more 
markedly than cytochalasin B (80% vs. 50% inhibition, respectively). However, phloretin (2 
mM) compromises cell viability (it caused a significant increase of extracellular LDH activity) 
and significantly decreases cell proliferation (Fig. 18). 
 
 
 
 
 
 
 
 
 
 
 Amax 
(pmol.mg prot-1) 
kin 
(μL.mg prot-1.min-1) 
kout 
(min-1) 
Control 15.40 ± 0.90  9.5 ± 1.5 0.031 ± 0.006 
Cyt. B 7.39 ± 0.82*  2.37 ± 0.38* 0.016 ± 0.004* 
Control Phloretin 2000 tBOOH 100 Phlor. + tBOOH
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Table 4: Analysis of the time course of 3H-DG apical uptake by BeWo cells. Cells were 
incubated in buffer with Na+ (control) or in buffer without Na+ and in the presence of 
cytochalasin B 50 µM (Cyt. B). Analysis allowed determination of the steady state 
accumulation (Amax) and the rate constant for inward (kin) and outward (kout) transport. 
Shown are arithmetic means ±SEM. *significantly different from control (P < 0.05) 
Figure 17: 
3
H-DG uptake by BeWo cells. Cells were exposed for 24h to tBOOH 100 µM 
or the respective solvent (control). After that, cells were incubated in buffer in the 
absence (control) or presence of phloretin (2 mM). *Significantly different from 
control (P < 0.05). 
#
significantly different from tBOOH 100 μM. 
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Contrary to phloretin, cytochalasin B´s effect on 3H-DG uptake was not related to a decrease 
in cell proliferation or viability (Fig. 19). So, cytochalasin B was chosen as the GLUT1 
inhibitor in the next series of experiments. 
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Figure 18: Effect of phloretin (2 mM) and tBOOH (100 μM) on cell viability (left panel) and cell proliferation (right 
panel). After a 24h-exposure of tBOOH 100 µM or its solvent (control), BeWo cellular viability was determined by 
quantification of extracellular LDH activity (n=6) and cellular proliferation was determined by quantification of 
whole cellular protein with SRB (n=6).*significantly different from control (P < 0.05). #significantly different from 
tBOOH 100 μM 
 
Figure 19: Effect of cytochalasin B (50 mM) and tBOOH (100 μM) on cell viability (left panel) and cell proliferation 
(right panel). After a 24h-exposure of tBOOH 100 µM or its solvent (control), BeWo cellular viability was determined 
by quantification of extracellular LDH activity (n=6) and cellular proliferation was determined by quantification of 
whole cellular protein with SRB (n=6). 
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In the next series of experiments, the time-course of 3H-DG uptake under control and 
oxidative stress conditions was analysed in the absence and presence of cytochalasin B 50 
μM. For that, cells were incubated at 37°C with 3H-DG for various periods of time (1, 5, 10, 30, 
90 and 120 min), in the absence or presence of a previous treatment with 100 μM tBOOH for 
24h. After that, cells were incubated in buffer with Na+ (total uptake) or in Na+-free buffer 
containing cytochalasin B 50 μM (non-GLUT-mediated uptake). GLUT-mediated uptake was 
obtained by subtracting non-GLUT-mediated uptake from total uptake. The results obtained 
show that tBOOH reduces both GLUT-mediated and non-GLUT-mediated 3H-DG uptake (Fig. 
20 and 21) as well as the Amax for GLUT-mediated and non-GLUT-mediated (Tables 5 and 6, 
respectively). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Amax 
(pmol.mg prot-1) 
kin 
(μL.mg prot-1.min-1) 
kout 
(min-1) 
Control 7.4 ± 0.8 2.366 ± 0.383 0.016 ± 0.004 
tBOOH 4.5 ± 0.3* 2.600 ± 0.556  0.029 ± 0.007 
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Figure 20: Time-course of non-GLUT-mediated 
3
H-DG uptake, by BeWo cells. 
Cells were exposed for 24h to tBOOH 100 µM or the respective solvent 
(control). After that, cells were incubated in Na+-free buffer in the presence 
of cytochalasin B 50 μM (non-GLUT-mediated uptake), containing 50 nM 
3
H-
DG, for various periods of time (n=6-17). 
 
Table 5: Analysis of the time course allowed determination of the steady state 
accumulation (Amax) and the rate constant for inward (kin) and outward (kout) 
transport. Shown are arithmetic means ±SEM. *significantly different from control 
(P < 0.05). 
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 Amax 
(pmol.mg prot-1) 
kin 
(μL.mg prot-1.min-1) 
kout 
(min-1) 
Control 8.8 ± 0.7 7.9 ± 2.1 0.05 ± 0.01 
tBOOH 6.4 ± 0.5* 14.5 ± 3.5 0.10 ± 0.03 
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Figure 21: Time-course of GLUT-mediated 
3
H-DG uptake, by BeWo cells. Cells 
were exposed for 24h to tBOOH 100 µM or the respective solvent (control). After 
that, cells were incubated in Na
+
-containing buffer (total uptake) or in Na
+
-free 
buffer in the presence of cytochalasin B 50 μM (non-GLUT-mediated uptake), 
containing 50 nM 
3
H-DG, for various periods of time (n=6-18). GLUT-mediated 
uptake was obtained by subtracting non-GLUT-mediated uptake from total 
uptake. Shown are arithmetic means ±SEM.  *significantly different from control 
(P < 0.05). 
Table 6: Analysis of the time course of GLUT-mediated 
3
H-DG uptake allowed 
determination of the steady state accumulation (Amax) and the rate constant for 
inward (kin) and outward (kout) transport. (Table above) Shown are arithmetic means 
±SEM. *significantly different from control (P < 0.05). 
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12.2.3 Effect of tBOOH upon GLUT1 mRNA levels 
Next, mRNA levels of GLUT1 were quantified, by qRT-PCR, in order to verify if tBOOH changes 
GLUT1 gene expression.  
 
 
 
 
 
The results, shown in Table 7, lead to the conclusion that the expression of GLUT1 is not 
significantly altered in response to oxidative stress induced by tBOOH.  
 
12.2.4 Effect of tBOOH upon lactate production 
Considering that cellular cultures perform mainly anaerobic glycolysis, we investigated if the 
decrease in glucose cellular uptake in response to tBOOH exposure, as assessed by the 
decrease in 3H-DG uptake, would cause also a decrease in anaerobic respiration rates. For 
that, we quantified lactate levels in both situations.   
 
 
 
 
 
 
The results demonstrate no significant difference between the amount of lactate present in 
cultures under normal and oxidative stress conditions (Table 8). 
(GLUT1/HPRT) Mean  SEM  n 
Control 0.15990 0.03312  5 
tBOOH 0.10494 0.02840 4 
Lactate Mean  SEM  n 
Control 27.730 0,736  17 
tBOOH 29.665 1.340 17 
Table 7: Results concerning GLUT1’s mRNA expression after a 24h-treatment of 
BeWo cells with tBOOH 100 μM or the respective solvent (control). HPRT is the 
housekeeping gene (hypoxanthine-guanine phosphoribosyltransferase). 
Table 8: Quantification of lactate (mmol.mg prot
-1
) in cells exposed for 24h to 
tBOOH 100 µM or to the respective solvent (control). Results are presented as 
arithmetic means ±SEM. 
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12.2.5 Involvement of PI3K and PKC on the effect of tBOOH 
In the next series of experiments, we evaluated if two intracellular pathways, 
phosphatidylinositol 3-kinases (PI3K) and protein kinase C (PKC),  that are activated during 
oxidative stress stimuli (70), and that can alter cellular glucose uptake (71, 72), were 
compromised by tBOOH. 
Chelerythrine 0.1 μM was used as an inhibitor of PKC pathway and LY 294002 1 μM was used 
as an inhibitor of PI3K/Akt pathway. 
 
 
 
 
 
 
 
 
The results concerning the influence of chelerythrine and LY 294002 show that neither of 
these compounds affected 3H-DG total uptake, whether in control conditions or in the 
presence of tBOOH (Fig. 22).  
 
12.2.6 Effect of some antioxidants 
Next, we decided to investigate in the observed effect of oxidative stress upon 3H-DG uptake 
could be reverted by antioxidants. 
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Figure 22: Influence of PI3K/Akt and PKC pathways (n=9-12) upon the decrease of 
3
H-DG uptake 
caused by a 24h-exposure of BeWo cells to tBOOH (100 µM).  Shown are arithmetic means ±SEM.  
*significantly different from control (total) (P < 0.05). 
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First, two inhibitors of ROS producing enzymes were analyzed: apocynin (1mM), an inhibitor 
of NADPH-oxidase, and allopurinol (1 mM), an inhibitor of xanthine oxidase. 
 
 
 
 
 
 
 
 
Results in Fig.23 show that none of the enzymes seem to be affecting 3H-DG uptake by cells, 
because their inhibition had no effect upon it. Moreover, inhibition of these enzymes, 
responsible for the production of ROS, also did not alter the effect of tBOOH. 
Then, some diet antioxidants were tested.  
Vitamin E (α-tocopherol 1 mM) showed no significant reversion of tBOOH’s effect upon 3H-DG 
uptake (Fig.24). Similar results, shown in Fig.25, were found for N-acetylcysteine (NAC) 0.1 
mM.  
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Influence of NADPH oxidase (apocynin 1mM) and xanthine oxidase (allopurinol 1mM) inhibitors (n=9) 
upon the decrease of 
3
H-DG uptake caused by a 24h-exposure of BeWo cells to tBOOH (100 µM). 
Shown are arithmetic means ±SEM. *significantly different from control (total) (P < 0.05). 
 
Figure 23: Influence of vitamin E 1 mM (n=9) upon the decrease of 
3
H-DG uptake caused by a 
24h-exposure of BeWo cells to tBOOH (100 µM). Shown are arithmetic means ±SEM.  
*significantly different from control (total) (P < 0.05). 
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Finally, we tested some diet polyphenols. Interestingly, resveratrol 50 μM (Fig.25), quercetin 
50 μM (Fig.26) and EGCG 50 μM (Fig.27), presented similar effects. For the three polyphenols, 
the polyphenol by itself did not shown a significant difference from the respective control 
but, together with tBOOH, a significant, although not complete, reversion of the oxidative 
stress effect of tBOOH on 3H-DG uptake was found. 
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Figure 24: Influence of NAC 1 mM (n=9) upon the decrease of 
3
H-DG uptake caused by a 24h-
exposure of BeWo cells to tBOOH (100 µM). Shown are arithmetic means ±SEM.*significantly 
different from control (total). (P < 0.05) 
Figure 25: Influence of resveratrol 50 μM (n=12) upon the decrease of 
3
H-DG uptake caused by a 24h-
exposure of BeWo cells to tBOOH (100 µM). Shown are arithmetic means ±SEM.*significantly different 
from control (total). 
#
significantly different from tBOOH 100 μM (P < 0.05) 
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Figure 26: Influence of quercetin 50 μM (n=12) upon the decrease of 
3
H-DG uptake caused by a 24h-
exposure of BeWo cells to tBOOH (100 µM). Shown are arithmetic means ±SEM. *significantly 
different from control (total). 
#
significantly different from tBOOH 100 μM (P < 0.05) 
Figure 27: Influence of EGCG 50 μM (n=12) upon the decrease of 
3
H-DG uptake caused by a 24h-
exposure of BeWo cells to tBOOH (100 µM). Shown are arithmetic means ±SEM. *significantly different 
from control (total). 
#
significantly different from tBOOH 100 μM (P < 0.05) 
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In Table 9, at bold, are presented the results that are significantly different, considering 
GLUT-mediated and non-GLUT mediated 3H-DG uptake, separately. The same kind of results 
is presented for quercetin (Table 10) and for EGCG (Table 11). 
 
 Uptake (% of control) 
TOTAL Non-GLUT mediated GLUT mediated 
Control  100.00 ± 1.90  46.58 ± 5.79 53.42 ± 5.85 
Resveratrol  98.64 ± 2.57 47. 10 ± 2.27 51.43 ±1.91 
tBOOH 56.42 ± 4.70 30.68 ±3.88 25.74 ± 3.29 
tBOOH + Resveratrol 84.42 ± 8.20 32.08 ± 3.50 52.34 ± 5.73 
 
 
 
 
 Uptake (% of control) 
TOTAL Non-GLUT mediated GLUT mediated 
Control  100.00 ± 1.90  46.58 ± 5.79 53.42 ± 5.85 
Quercetin  89.85 ± 5.27 42. 46 ± 4.58 47.39 ± 3.87 
tBOOH 56.42 ± 4.70 30.68 ±3.88 25.74 ± 3.29 
tBOOH + Quercetin 80.00 ± 8.82 33.33 ± 2.93 46.67 ± 6.17 
 Uptake (% of control) 
TOTAL Non-GLUT mediated GLUT mediated 
Control  100.00 ± 1.90  46.58 ± 5.79 53.42 ± 5.85 
EGCG 86.61 ± 4.91 36.38 ± 2.59 49.96 ± 3.71 
tBOOH 56.42 ± 4.70 30.68 ±3.88 25.74 ± 3.29 
tBOOH + EGCG 78.64 ± 12.82 33.04 ± 4.88 45.61 ± 8.32 
Table 9: Results of 
3
H-DG uptake regarding resveratrol. 
Table 10: Results of 
3
H-DG uptake regarding quercetin. 
Table 11: Results of 
3
H-DG uptake regarding epigallocatechin-3-gallate. 
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12.3 Effect of tBOOH on the transcellular transport of 3H-DG 
Fig. 28 represents the results regarding the 3H-DG transepithelial transport across BeWo 
cells. The graphic shows the apical-to-basolateral transepithelial transport of 3H-DG uptake 
with time, while the inset (up on the left of the graphic) shows the apical 3H-DG uptake, at 
120 min.  
Concerning the apical uptake, the results are in agreement with the already presented 
(section 7.2.1. - Effect of tBOOH on total uptake), showing a significant decrease in 3H-DG 
apical cellular uptake.  
Results concerning the apical-to-basolateral transport show that 3H-DG transepithelial 
transport increases with time, in a linear manner, both in the absence and presence of tBOOH. 
Moreover, in the presence of tBOOH, apical-to-basolateral 3H-DG transport is higher than 
control (Fig. 28).  
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Figure 28: Apical-to-basolateral transepithelial transport of 
3
H-DG, in normal conditions (control) and 
under oxidative stress (tBOOH) (n=6). The inset represents the 
3
H-DG apical cellular 
uptake.*significantly different from respective control. (P < 0.05) 
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The Papp (apparent permeability) was calculated in the absence and presence of tBOOH and 
results are presented in Table 12. The mean value, for an n of 6, of control was 1,676 x 10-03 ± 
1,057 x 10-04 cm/s, while for tBOOH was 2,743 x 10-03 ± 2,494 x 10-04 cm/s. So, tBOOH causes 
an increase in Papp of 3H-DG in the apical-to-basolateral direction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Papp 
(cm/s) 
Mean  SEM  n 
Control 1,676 x 10-03 1,057 x 10-04 6 
tBOOH 2,743 x 10-03 * 2,494 x 10-04 * 6 
Table 12: Apical-to-basolateral apparent permeability (Papp) to 
3
H-DG across 
BeWo cells in normal conditions (control) and under oxidative stress (tBOOH). 
*significantly different from respective control. (P < 0.05) 
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Based on previous studies, tBOOH was chosen as an inducer of oxidative stress in the BeWo 
trophoblastic cell line, BeWo (35, 63, 64). From tBOOH, tested at 1, 3, 10, 30, 100, 300 and 1000 
μM, the proper concentration was chosen, after the evaluation of cell integrity and important 
oxidative stress biomarkers. Based on the assays of cell viability (LDH leakage) and cell 
proliferation (SRB assay), we concluded that cell integrity is compromised for the two highest 
concentrations of tBOOH (300 and 1000 μM).  
Taking these results into consideration, the evaluation of the following oxidative stress 
biomarkers was conducted for tBOOH 10, 30, 100 μM: glutathiones, lipid peroxidation and 
carbonylated proteins. 
Glutathiones (GSH) are thiol-containing tripeptides (γ-glutamyl-cysteinyl-glycine) that have a 
major role in cellular protection against the toxicity induced by oxidant agents. Several 
studies show that GSH possesses a number of important functions implicated in cell 
physiology and pathophysiology, such as DNA synthesis and cell proliferation, regulation of 
nuclear matrix organization and maintenance of Cys residues on zinc-finger DNA-binding 
motifs in a reduced and functional state (73).  The millimolar levels of cellular GSH (5-10 mM) 
are distributed mainly between the cytosolic (about 80-85%) and mitochondrial (10-15%) 
compartments and the ratio [GSH]2/[GSSG] determines the cellular redox state, with GSH 
representing the reduced form and GSSG the oxidized form (46, 73). ROS glutathione peroxidase 
(GPx) catalyzes the reduction of H2O2 or organic hydroperoxides to H2O and respective 
alcohols by using GSH as a reductant. Simultaneously, the Cys residues of GSH are oxidized 
forming disulfides (S-glutathionylation), so it is expected that increased levels of oxidative 
stress implicate a lower [GSH]2/[GSSG] ratio (33, 74). Using colorimetric and enzymatic assays it 
was possible to quantify these two forms, by calculating their levels through the reaction GSx 
= GSH + 2 GSSG, with GSx being total glutathione (75). 
 
 
 
 
 Figure 29: Interconversion of glutathione (GSH) and GSSG in the 
presence of reactive oxygen species (ROS), which are non-
enzymatically reduced by GSH. 
(1)
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Glutathiones levels were assessed for the three highest tBOOH concentrations that did not 
compromise cell integrity (10, 30 and 100 μM). It was concluded that total glutathione levels 
(GSx) were significantly increased for tBOOH 30 and 100 μM and that GSSG levels were 
significantly increased for tBOOH 100 μM. Since the ratio [GSH]2/[GSSG] decreases as 
oxidative stress levels increase (as already mentioned in Introduction), these results indicate 
that tBOOH 100 μM would be the proper concentration to induce oxidative stress on cells 
without compromising its integrity.  
Nevertheless, lipid peroxidation, as well as carbonylated proteins, was measured.  
Lipid peroxidation is a process that depends on the presence of free radicals and is involved 
in the modification of membrane structure and permeability, age pigment formation, 
oxidative modification of low-density lipoproteins and alteration of vasomotor tone 
regulation (63). 
Mammalian cells contain 1500-2000 lipid species. (76) Unsaturated lipids have methylene (-
CH2) groups, where hydrogens are particularly reactive. ROS have the ability to scavenge 
electrons from these groups, forming a lipid radical, which then can react with oxygen and 
other fatty acids to produce lipid hydroperoxides. It is a chain reaction that can significantly 
alter the membranes’ fluidity, permeability transport and metabolic processes. Fatty acid 
peroxides can give rise to various aldehydes with proven toxicity, such as like 4-hydroxy-2-
nonenal, that causes extensive damage and results in apoptosis. There are also aldehydes, 
mainly α,β-unsaturated reactive aldehydes, resulting from lipid peroxidation and, because 
they are more stable than ROS, they can serve as “second cytotoxic messengers” and react 
with proteins’ side chains, forming carbonylated proteins, for example (already mentioned 
above). A good example is malondialdehyde (MDA), a physiologic ketoaldehyde that is 
produced in excess as a result of tissue injury and reacts mainly with L-Lys residues by 
Michael addition. Modification of proteins by MDA can alter their biological properties and 
their immunogenic (33, 76, 77).  
Carbonyl (CO) groups, aldehydes and ketones, are chemically stable compounds that result 
from oxidative stress and, therefore, constitute a reliable way to verify cell damage. In fact, 
protein carbonyl content is by far the most common used marker of protein oxidation and its 
accumulation has been related to several human diseases like Alzheimer, diabetes, 
inflammatory bowel disease and arthritis, naming just a few. For example, analysis of plasma 
proteins of children with different forms of chronic arthritis showed significantly higher 
carbonyl levels when compared with healthy children. The same has been observed in 
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patients with acute pancreatitis, chronic kidney disease and Alzheimer, confirming that this 
protein modification can be a useful plasma marker of oxidative stress (33, 34). CO groups have 
several sources, such as oxidation of aminoacid (namely Pro, Arg, Lys and Thr) side chains, 
oxidative cleavage of proteins by α-amidation pathway or glutamyl side chains, or even by 
secondary reaction of a nucleophilic side chain of Cys, His, and Lys residues, with aldehydes, 
produced during lipid peroxidation, or with reactive carbonyl derivates, generated during 
sugars’ reduction, for example (33, 34).  
Although protein CO groups can be induced by almost all ROS’ types, not being very 
conclusive about the source of the oxidative stress, their content evaluation, together with 
other biomarkers, constitute a solid indicator about the cell’s integrity (34).  
The results obtained reinforced the previous conclusion, as MDA levels and carbonylated 
proteins were significantly increased by tBOOH 100 μM. Therefore, tBOOH 100 µM (24 h) 
was used in all subsequent experiments.  
In this work, glucose uptake was studied by using 3H-DG as a substrate. DG is a D-glucose 
analogue that is efficiently transported by facilitated glucose transporters such as GLUT1 and 
GLUT2, but is poorly transported by SGLT1 (78). Moreover, once inside cells, this compound is 
phosphorylated by hexokinase to 2-deoxy-D-glucose-6-phosphate, which is metabolically 
inactive and poorly transportable across biological membranes (78). So, accumulation of 3H-
DG-6-phosphate in cells is a good estimate of 3H-DG rates of uptake.  
To evaluate if glucose uptake would be altered under oxidative stress condition, a time-
course of 3H-DG uptake was conducted. The results showed that tBOOH inhibited 3H-DG 
uptake in a time-dependent manner, causing a decrease in Amax of 3H-DG uptake. Also, 
analysis of the effect of tBOOH over time showed that its effect upon 3H-DG uptake was 
maximal at 120 min of incubation. Based on these results, a 120 min incubation time was 
chosen as the standard incubation for subsequent experiments. 
Observation of an inhibitory effect of tBOOH upon 3H-DG uptake originated some questions: 
1. Is this effect a result of changes in GLUT activity /transcription rates?  
2. Will this inhibitory effect reflect upon intracellular lactate levels? 
3. Is this effect dependent on the activation of intracellular signaling pathways? 
4. Can the effect be reversed with antioxidants? 
5. Will this effect cause a decrease in the transepithelial transport of 3H-DG? 
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To answer the first question, a GLUT inhibitor, cytochalasin B (50 μM), was used in transport 
assays. Cytochalasin B is a largely used compound to study the role of GLUT transporters in 
the uptake of glucose. There have been reports of inhibition from 50% up to 85%, varying 
according, among other features, the concentration of the inhibitor and glucose (26, 27). In our 
experimental conditions, about 50% of 3H-DG uptake by BeWo cells seems to be GLUT-
mediated. Under oxidative stress conditions (tBOOH), both GLUT- and non-GLUT-mediated 
3H-DG uptake were decreased. Moreover, the mRNA levels of GLUT1 were quantified and no 
significant difference under normal or oxidative conditions was found, which means that 
there is probably no significant alteration in GLUT1 transcription rates. 
 
We also investigated if there could be a more efficient GLUT inhibitor, causing a higher degree 
of inhibition of 3H-DG uptake, i.e., if the GLUT-mediated component of 3H-DG uptake was 
underestimated by using cytochalasin B. So, we tested phloretin (2 mM). This compound, at 
this concentration, was used in a study about transepithelial glucose transport in the same 
cell line (25). We could conclude that, although phloretin caused a higher degree of inhibition 
of 3H-DG uptake (around 80%) than cytochalasin B, it also compromises cell viability (LDH 
activity assay) and cell proliferation (SRB assay). So, the marked inhibitory effect of phloretin 
upon 3H-DG uptake is most probably related to the decrease in cell viability and proliferation. 
Of note, the mentioned study (25) affirms that phloretin (2 mM) completely inhibited 
transcellular glucose transport, but the effect of this compound on cell integrity was not 
available. So, taking in consideration the results obtained with phloretin, along with the fact 
that cytochalasin B was previously used by our group (27), and does not affect cell integrity, 
cytochalasin B 50 μM appears to be an appropriate inhibitor to define GLUT-mediated 
transport.  
Concerning the second question, we could conclude, by measuring lactate levels in control 
and tBOOH-treated cultures, that inhibition of 3H-DG uptake by tBOOH did not cause a 
significant decrease in the amount of lactate produced by the cells.  
Two pathways that are activated during oxidative stress stimuli, PI3K/Akt and PKC, were 
investigated in order to understand if they are involved in the effect of tBOOH upon 3H-DG 
uptake.  
PKC is a serine/threonine-related protein kinase that plays a key role in many cellular 
functions and affects many signal transduction pathways. There are multiple isoforms of PKC 
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that function in a wide variety of biological systems. All PKCs contain a C-terminal kinase 
domain and an N-terminal regulatory domain. Based on primary structure and biochemical 
characteristics, for instances regulatory domains, these enzymes can be divided into three 
subfamilies: classical or conventional PKCs (PKC-α, -β1, -β2, and -γ), novel PKCs (PKC-δ, -ε, -θ, 
and -η) and atypical PKCs (PKC-ζ and -ι/λ), where the first subfamily depends on Ca2+ and 
diacylglycerol (DAG) for activation, the second depends on DAG and the third does not 
depend of either (79, 80). Human placental trophoblasts contain at least three PKC isoforms: α, ε 
and ζ. So, one member from each of the PKC subfamilies can be detected in trophoblasts. (81) 
Another study showed that PKC β2, δ, ε and ζ were found to be present in both microvillous 
and basal membranes from term placenta. The -α isoform was observed only on the basal 
membrane while the -β1 isoform was confined to the microvillous membrane. The basal to 
microvillous ratios for -β2, -γ, -ε and -ζ ranged between 0.3 and 0.5, demonstrating a 
substantial asymmetry in plasma membrane localization and immunocytochemistry 
techniques supported the isoform identification and localization observed in the 
immunoblotting experiments (82).  
When activated, for example at increased levels of glucose, PKC can catalyze the 
phosphorylation of specific residues of target proteins and thus can alter their activity and 
consequently cellular metabolism.  
In investigations conducted to study this pathway, some inhibitors are used; among them, 
chelerythrine (83-85).  
As for PI3K, it is a lipid heterodimeric kinase that phosphorylates the D-3 position on the 
inositol ring in phosphoinositides. There are a number of extracellular signals that activate 
PI3K, such insulin and other growth factors (71). PI3K/Akt activation promotes glucose 
metabolism and is dependent on it to inhibit cell death.  
PI3K interacts with insulin receptor substrate, phosphorylating it, resulting in the 
recruitment of the serine-threonine kinase Akt to the plasma membrane. At the membrane, 
Akt becomes itself phosphorylated. Akt can promote aerobic glycolysis through increased 
trafficking of GLUT1 to the cell surface, activation of phosphofructokinase and hexokinase 
activity and stimulation of mTOR (71, 72, 74). LY294002 is known to be a specific inhibitor of the 
PI3K/Akt kinase pathway (86, 87).  
Using chelerythrine (0.1 μM) as an inhibitor of PKC pathway and LY 294002 (1 μM) as an 
inhibitor of PI3K/Akt pathway, we could conclude that these pathways are not involved in 
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the inhibitory effect of tBOOH upon 3H-DG uptake. The PI3K/Akt pathway is described as 
glucose metabolism-dependent, but in apoptotic conditions (71, 72). Since oxidative stress 
imposed by tBOOH was performed under controlled levels, it probably does not constitute an 
enough cell insult leading to activation of this pathway. In relation to the PKC pathway, it is a 
pathway described as possibly activated under increased glucose levels (81). The results 
presented in this work show a decrease in amount of 3H-DG taken up by the cells, which may 
be the explanation for the results shown for this pathway. 
In the final part of this work, a number of antioxidants were used in order to investigate if 
they could reverse the effect of tBOOH upon 3H-DG uptake.  
First, two inhibitors of endogenous enzymes responsible for ROS formation were studied: 
apocynin (1 mM), an inhibitor of NADPH-oxidase, and allopurinol (1 mM), an inhibitor of 
xanthine oxidase. NADPH-oxidase and xanthine-oxidase are two enzymes that, during 
important metabolic pathways, produce ROS, in particular superoxide. Apocynin has been 
considered a therapeutic agent in atherosclerotic disease, ozone-induced bronchial 
hyperresponsiveness, and asthma, among others (88). Results showed that inhibition of these 
enzymes did not affect the inhibitory effect of tBOOH upon 3H-DG uptake; so, it can be 
concluded that the effect of tBOOH is not dependent upon ROS produced by these enzymes in 
BeWo cells.   
The antioxidants α-tocopherol (1 mM) and N-acetylcysteine (NAC) (0.1 mM) were also tested. 
NAC is an antioxidant that increases intracellular glutathione levels by acting as a precursor 
in glutathione biosynthesis and as a stimulator of cytosolic enzymes involved in glutathione 
regeneration (89). α-tocopherol, as already mentioned in Introduction, is an antioxidant that 
influences cell membranes’ permeability by protecting the latter from free radicals and 
stabilizing cells in culture (48). Although the antioxidant capacity of both α-tocopherol and 
NAC are widely recognized, results regarding these two compounds showed no significant 
reversive effect upon 3H-DG uptake. This might be due to the fact that the oxidative effect 
induced by tBOOH overcomes the potential antioxidant effect of these compounds. Moreover, 
α-tocopherol is a hydrophobic antioxidant and, since the buffer used in all transport 
experiments had water as the solvent, there is the doubt if the poor solvation of this vitamin 
might have influenced the results. 
Three more antioxidants were tested: resveratrol, quercetin and EGCG ((-) epigallocatechin-
3-gallate). These three polyphenols belong to a complex family of phytochemicals that 
possess several hydroxyl groups on aromatic rings (90). 
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Molecular structure Characteristics 
 RESVERATROL has been proven to be a powerful 
anti-inflammatory agent, detoxifier of superoxide, 
cancer chemopreventive, anti-mutagenic and anti-
initiative agent, a COX-1 and COX-2 enzymatic 
inhibitor and a suppressor of PKC- and AP-1 mediated 
gene expression (91). It is found in grapes, red wine and 
mulberries, to name a few (91). 
 QUERCETIN has been proven to chelate iron, which is 
involved in the hydroxyl radical generation and, along 
with rutin, seems to have the ability to protect DNA 
single strand breaks induced by tBOOH, an oxidative 
stress inducer (35, 92). 
 EPIGALLOCATECHIN-3-GALLATE (EGCG) is isolated 
from green tea and has demonstrated 
chemopreventive and chemotherapeutic actions in 
cellular and animal models of cancer (93, 94).  EGCG 
selectively induces apoptosis in human carcinoma cell 
lines (93, 94).  interferes with angiogenesis (95),  inhibits 
telomerase and DNA methyltransferase (96) and 
protects cells from lipid peroxidation and DNA 
damage induced by reactive free radicals (97). 
 
Results regarding these three antioxidants are quite interesting: all three showed a partial 
reversive effect in relation to the decrease of 3H-DG uptake induced by tBOOH. From the 
analysis of Table 9, presented in chapter results, we can see that under normal conditions and 
in the presence of resveratrol, the 3H-DG uptake remains unaffected. Under oxidative stress 
Table 13: Characteristics regarding resveratrol, quercetin and epigallocatechin-3-gallate. 
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conditions, like already discussed above, the total 3H-DG uptake is reduced by more than 
30%. However, resveratrol seems to reverse the effect induced by tBOOH in more than 60%. 
For quercetin (Table 10) and EGCG (Table 11), the results are similar for total uptake, with a 
reversion of around 50% and 45% of the effect of tBOOH, respectively. Interestingly, the 
overall analysis shows that the polyphenol reverses completely the effect of tBOOH upon 
GLUT-mediated uptake.  
To answer the last question, one last set of experiments was conducted, in order to 
investigate if the decrease in apical 3H-DG uptake caused by tBOOH would originate a 
decrease in the apical-to-basolateral transepithelial transport of 3H-DG. The results showed 
that, although tBOOH reduced the apical cellular uptake of 3H-DG, it increased the apical-to-
basolateral transport of 3H-DG (Papp). From these results, several considerations and 
hypothesis can be considered. 
One of the hypotheses proposed is that tight junctions might be compromised in the presence 
of tBOOH, this affecting (increasing) the paracellular transport of 3H-DG.  
Schematizing the hypothesis, the red arrow symbolizes the increase in the passage of 3H-DG 
across the tight junctions. There have been studies that support this hypothesis, where 
tBOOH seems to induce the opening of tight junctions (98, 99).  
 
 
                            
 
 
Another hypothesis would be to consider alterations in GLUT transporters’ activity at the 
basolateral membrane, due to tBOOH inhibiting the uptake of basolateral 3H-DG into the cells. 
In order to corroborate these hypotheses, more studies should be conducted, so that 
conclusions about this increase in apical-to-basolateral 3H-DG transport, together with a 
decrease in the apical uptake, could be taken.  
 
Apical  
Basolateral  
Intermembranous placental space 
Discussion 
83 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of oxidative stress upon absorption of glucose by the human placenta: in vitro studies with BeWo cells 
84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 85 
 
14 Conclusions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of oxidative stress upon absorption of glucose by the human placenta: in vitro studies with BeWo cells 
86 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusions 
87 
 
The purpose of this study was to find out if the uptake of glucose, the fetus’ primary source of 
energy, would be compromised under oxidative stress conditions. Based in previous studies, 
tBOOH was chosen as an inducer of oxidative stress in the trophoblastic cell line, BeWo (35, 63, 
64). The proper concentration, tBOOH 100 μM, was chosen after the evaluation of cell integrity 
and important oxidative stress biomarkers, being the concentration that induced higher 
oxidative stress levels, without compromising cell integrity. 
To evaluate if glucose uptake would be altered under oxidative stress condition, a time-
course of 3H-DG uptake was conducted. Results showed that, under normal conditions, 48% 
of the apical 3H-DG uptake seems to be non-GLUT mediated, leaving 52% of the uptake to 
GLUT mediation. Under oxidative stress induced by tBOOH 100 μM, the Amax of total 3H-DG 
uptake decreases 33%, through a decrease of 40% of the non-GLUT mediated uptake and of 
28% of the GLUT-mediated uptake. However, results of GLUT1 mRNA levels showed no 
significant alteration under oxidative stress conditions induced by tBOOH, as well as cellular 
lactate production. 
The PKC and the PI3K/Akt pathways were also evaluated under oxidative stress conditions 
and results showed that these two pathways do not seem to be involved in the inhibitory 
effect of tBOOH upon 3H-DG uptake. 
In the final part of this work, a number of antioxidants were used in order to investigate if 
they could reverse the effect of oxidative stress upon 3H-DG uptake. Among all antioxidants 
tested, the polyphenols resveratrol, quercetin and EGCG showed interesting results. With all 
three, the effect of tBOOH upon 3H-DG uptake was reversed in, at least, 45%, being this 
increase the result of an increase in GLUT-mediated 3H-DG uptake. This shows that, quite 
possibly, tBOOH, in the presence of the polyphenol, inhibits the non- GLUT mediated uptake 
of 3H-DG, while the polyphenol reverses the effect of tBOOH upon GLUT-mediated uptake of 
3H-DG.  
In relation to the transepithelial 3H-DG transport, results were also very interesting. Although 
apical cellular uptake of 3H-DG decreased in the presence of tBOOH, the apical-to-basolateral 
transport of 3H-DG increased in the same conditions. In order to understand these results, 
more studies are required. So, all findings and conclusions lead to a number of questions: 
Would results be any different if another oxidative stress inducer was used? Despite the 
apparent unaltered mRNA amount, could there be a different GLUT1 protein amount at the 
membrane and/or a different intrinsic GLUT1 activity? Would higher antioxidants’ 
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concentrations imply a more marked reversive effect of tBOOH? Would results corroborate or 
contradict the ones found in this project if studies were conducted in another cell line, for 
instance primary cultures of human trophoblasts, or even in vivo? 
Considering that many pregnancy pathologies are associated with increased oxidative stress 
levels, as well as with deregulated glucose levels, the findings in this project shows a relevant 
first step in order to understand the impact that oxidative stress might have in the uptake of 
such fundamental fetal nutrient: glucose. 
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